CRP and cancer: Unadjusted competing-risk analysis revealed that CRP levels >2 mg/L conferred a 1.12-fold higher risk of cardiovascular death in cancer survivors compared to CRP ≤2 mg/L (sub-distribution hazard ratio [sHR]: 2.12; 95% CI: 1.40-3.21; P < 0.001).